EDMA
Jump to navigation
Jump to search
| File:EDMA.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| Chemical and physical data | |
| Formula | C12H17NO2 |
| Molar mass | 207.2694 |
EDMA, or 3,4-ethylenedioxy-N-methylamphetamine, is a lesser-known psychedelic drug and a substituted Amphetamine. EDMA was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the minimum dosage is listed as 200 mg, and the duration listed as 3-5 hours.[1] EDMA produces hypnogogic imagery and empathogenic, non-psychedelic MDMA-like effects. It generally has a threshold, and no other effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of EDMA.
Reference
External link
Categories:
- Articles with short description
- Pages with broken file links
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Psychedelic phenethylamines